Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole for Stage 1 or Early Stage 2 HAT
NCT02169557Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Apr 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fexinidazole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Apr 2014; status: completed.
02
Drugs
Fexinidazole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT02169557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169557.